US › Healthcare

Vivani Medical Inc. (VANI)

US · Healthcare · Biotechnology

$1.21-0.82%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-6.4M

EPS

$-0.07

EPS estimate

$-0.08

EPS came in at -0.07 against a street estimate of -0.08 — a beat of 12.5%.

Key statistics

Market cap

$114.6M

Forward P/E

0.0

P/B

5.94

Book value

$0.21

EPS (TTM)

$-0.36

52-week high

$1.92

52-week low

$0.92

50-day MA

$1.37

200-day MA

$1.28

Beta

3.28

Analyst view

Analysts rate Vivani Medical Inc. a buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $3.83.

Shareholding

Insiders

55.39%

Institutions

5.89%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	1.70%
Tanager Wealth Management LLP	0.67%
Geode Capital Management, LLC	0.67%
Tudor Investment Corp Et AL	0.47%
UBS Group AG	0.37%
Commonwealth Equity Services, LLC	0.37%
BlackRock Inc	0.33%
Vanguard Fiduciary Trust Co	0.29%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Vivani Medical Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.